Drug Patents owned by Alkermes

1. List of Vivitrol drug patents

VIVITROL Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7919499 ALKERMES Naltrexone long acting formulations and methods of use
Oct, 2029

(6 years from now)

Do you want to check out VIVITROL patents from before 2022?

Drugs and Companies using NALTREXONE ingredient

Market Authorisation Date: 13 April, 2006

Treatment: Prevention of relapse to opioid dependence, following opioid detoxification; Treatment of alcohol dependence

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

How can I launch a generic of VIVITROL before it's patent expiration?
More Information on Dosage

VIVITROL family patents

17

United States

2

Korea, Republic of

2

China

2

Japan

2

European Union

1

New Zealand

1

Russia

1

South Africa

1

Canada

1

Australia

1

United Kingdom

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in